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ABSTRACT Globin messenger RNA, isolated from
human peripheral blood reticulocytes, was transcribed
into complementary DNA by use of the RNA-dependent
DNA polymerase of avian myeloblastosis virus. The com-
plementary DNA was then transcribed into '2P-labeled
complementary RNA by E. coli RNA polymerase in the
presence of a-32P-labeled ribonucleoside triphosphates.
The fingerprint pattern obtained from ribonuclease Ti
digests of human globin complementary RNA was specific
and reproducible. Different patterns were obtained from
digests of duck, mouse, and rabbit globin complementary
RNA. The fingerprint patterns obtained from digests of
purified natural human lOS globin messenger RNA, labeled
in vitro with 12I1 or with [y-32P]ATP and polynucleotide
kinase, were similar to that of the complementary RNA
but contained some additional oligonucleotides. Sufficient
nucleotide sequence information has been obtained from
about 50% of the intermediate sized oligonucleotides (8-14
base residues long), to make possible examination of corre-
spondence between these nucleotide sequences and globin
amino-acid sequences. Approximately 70% of these
oligonucleotide sequences can be matched to unique
amino-acid sequences in the a- or jB-globin chains. The
other 30% do not match known amino-acid sequences and
presumably correspond to untranslated portions of the
mRNA; some of these sequences, however, can be matched
to amino-acid sequences in the abnormally long segment
of the a chain of hemoglobin Constant Spring, which is
thought to result from a chain-termination mutation.
The study of the nucleotide sequence of human globin mes-
senger RNA (mRNA) provides a means to examine the
molecular genetics of normal and abnormal human hemo-
globin synthesis. Such studies are particularly relevant be-
cause there exist in man a large number of hereditary dis-
orders that affect the structure and/or rate of synthesis of one
or the other human globin chain, and that are presumed to be
the consequence of single base substitutions in the mRNA or
due to quantitative deficiency of chain-specific mRNA.
It is possible to isolate functional human globin mRNA
from peripheral blood reticulocytes, and have it translated
in various cell-free protein-synthesizing systems (1-3). How-
ever, most techniques used in RNA sequencing rely on auto-
radiography of fractionated digests of 32P-labeled RNA of
high specific radioactivity (4). Because it is not possible to
Abbreviations: cDNA, DNA synthesized from mRNA by DNA
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thesized from cDNA by Escherichia coli RNA polymerase;
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obtain 82P-labeled human globin mRNA by in vivo or cell
culture labeling techniques, we have used a different ap-
proach to obtain 82P-labeled RNA. Globin mRNA is an
efficient substrate for the RNA-dependent DNA polymerase
(or reverse transcriptase) of avian myeloblastosis virus (5-7):
in the presence of oligo(dT), which serves as a primer pre-
sumably by binding to a poly(A) sequence situated at the
3'-terminus of the RNA, a DNA copy (cDNA) of the mRNA
is synthesized (5-7). In the presence of actinomycin D, the
cDNA synthesized is single-stranded, and can be shown to
be nearly 100% complementary to the globin mRNA by
hybridization assays (5). We have used the globin cDNA as a
substrate for the DNA-dependent RNA polymerase of
Escherichia coli: in the presence of [ac-2P]ribonucleoside
triphosphates, we obtained the synthesis of a 32P-labeled
RNA (cRNA) of high specific radioactivity, which was shown,
after analysis by standard RNA sequencing techniques, to
contain most of the nucleotide sequence information of the
natural 10S human globin mRNA. The fingerprint pattern
of the cRNA is similar to that of digests of purified natural
10S RNA labeled in vitro by different techniques, and most
of the nucleotide sequences identified can be matched to
amino-acid sequences of the a- or ,3-globin chains of human
hemoglobin (Hb) A [a2#21; other sequences cannot be matched,
and presumably correspond to untranslated sequences of the
mRNA.
MATERIALS AND METHODS
Materials. a-2P-labeled ATP, GTP, CTP, and UTP
(specific activity 50-150 Ci/mmole), [,y-_2P]ATP (20 Ci/
mmole), and 125I (carrier free) were obtained from the New
England Nuclear Corp. [3H]dGTP (10-15 Ci/mmole) was
obtained from Schwarz-Mann or New England Nuclear.
Oligo(dT)12-18 and oligo(dT)-cellulose (type T2) were ob-
tained from Collaborative Research, Inc., Waltham, Mass.
The RNA-dependent DNA polymerase of avian myeloblasto-
sis virus was purified from virions as described (8-10). The
DNA-dependent RNA polymerase of E. coli was the gift of
Dr. P. Lebowitz and was isolated and purified as described
(11). DNase, electrophoretically purified, was obtained from
Schwarz-Mann. Polynucleotide kinase (EC 2.7.1.78; ATP:
5'-dephosphopolynucleotide 5'-phosphotransferase) was puri-
fied from phage T4-infected E. coli cells (12). Purified E. coli
alkaline phosphatase (EC 3.1.3.1) (RNase free) was the gift
of Drs. J. Coleman and J. Taylor, and was prepared as de-
scribed (13). Materials used in nucleotide sequence techniques
(4, 14-17) have been described.
Preparation of Human Globin mRNA. Total cellular RNA
was prepared from membrane-free lysates of reticulocyte-
rich peripheral blood, by detergent and phenol-cresol extrac-
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tion (2, 18); the RNA was then fractionated by sucrose gradi-
ent centrifugation. The RNA sedimenting between 4 S and
18 S was precipitated with ethanol (18) and served as a par-
tially purified mRNA fraction for synthesis of cDNA. In some
cases, the RNA was further fractionated by acrylamide gel
electrophoresis (19); then the lOS RNA was electrophoreti-
cally eluted (20), and used for cDNA synthesis.
The pure 10S globin mRNA used in the labeling experi-
ments in vitro, was obtained by oligo(dT)-cellulose column
chromatography (21) of the partially purified sucrose gradi-
ent mRNA fraction. The RNA eluted from the column by 10
mM Tris-HCl (pH 7.5), consisted of a single 1OS RNA band
when analyzed by electrophoresis on 5% acrylamide gels.
Synthesis of DNA Complementary to Globin mRNA. Single-
stranded DNA complementary to globin mRNA was pre-
pared by incubating the mRNA with the DNA polymerase of
avian myeloblastosis virus (5); a typical reaction contained in
0.2 ml: 10 ,g of 1OS RNA; 5,g/ml of oligo (dT)12.18; 1 mM
each dATP, dCTP, and dTTP; 0.2 mM dGTP; [8H]dGTP
(25,uCi/ml; fijnal specific activity 40-60 cpm/pmole); 100
pug/ml of actinomycin D; 30 pl [15-20 units (9)] of purified
DNA polymerase; 10 mM dithiothreitol; 6 mM magnesium
acetate; 60 mM NaCl; and 50 mM Tris-HCl, pH 8.3. After
incubation for 90-180 min at 370, the solution was heated for
5 min in the presence of 0.3 N NaOH, at 100°, then neutralized
with HC1 and fractionated by gel filtration on Sephadex G-50
columns equilibrated with 0.05 M triethylamine bicarbonate
(pH 7.0). The fractions containing the excluded material
were pooled and lyophilized; the residue was resuspended in
H20 and used for synthesis of complementary RNA.
Synthesis of Globin cRNA. The preparation and purification
of RNA transcripts from globin cDNA using E. coli RNA
polymerase and [a-'2P]ribonucleoside triphosphates is de-
scribed (14). In summary, 1-3 pg of cDNA was incubated
with 5 pg of RNA polymerase in the presence of 0.18 M KC1,
33 mM Tris*C1 (pH 7.9), 3.3mM MgCI2, 6.0mM mercapto-
ethanol, three nonradioactive ribonucleoside triphosphates,
(0.165 or 0.33 mM each), and 1-2 mCi (0.165 mM) of the
fourth ribonucleoside triphosphate labeled with 82p in the a
position. After incubation at 370 for 50 min, an additional
5 pug of RNA polymerase were added and the mixture was in-
cubated for 10 more minutes at 37°. Finally, the reaction was
terminated by adding 2 pg of DNase, incubating for 5 min
at 370, then adding sodium dodecyl sulfate to 0.25%, and
extracting the mixture with phenol. The 82P-labeled RNA
was separated from the nonincorporated [(2PJtriphosphate by
gel filtration over a column of Sephadex G-100, equilibrated
with 10 mM Tris*HCl (pH 7.9), 10 mM MgCI2, and 0.1 mM
EDTA, then precipitated with ethanol in the presence of
carrier RNA (14). The properties of rabbit globin cRNA have
been described (39).
In Vitro Labeling of Natural mRNA. Pure 10S mRNA
[purified by oligo(dT)-cellulose column chromatography] was
digested simultaneously with T1 RNase and E. coli alkaline
phosphatase. Then the 5'-terminus of each resulting oligo-
nucleotide was labeled by incubating the digest in the presence
of ['y-82P]ATP and polynucleotide kinase (23, 24). Intact pure
10S RNA was labeled with 125I by the method of Commerford
(25). These techniques have been used by others to label
globin mRNA for fingerprint analysis (24, 37).
RNA Sequence Analysis Procedures. General RNA sequence
analysis methodology has been described (4, 14-17). The
32P-labeled cRNA was completely digested with T1 RNase
either directly after Sephadex G-100 gel filtration or after ad-
ditional purification by (Me)2SO-sucrose gradient centrifuga-
tion. Fingerprints were then prepared by electrophoresis of
the digests on urea-Cellogele strips, followed by homochro-
matography (14, 17).
RESULTS
Size of the Globin cRNA. The '2P-labeled RNA isolated
after incubation of human globin cDNA with E. coli RNA
polymerase was fractionated by (Me)2SO-sucrose gradient
centrifugation (22) and by acrylamide gel electrophoresis in
formamide (36) in order to determine its size. After (Me)2SO-
sucrose gradient centrifugation, the peak of radioactive cRNA
sedimented slightly slower than 6 S, using as a standard the
6S RNA transcribed from the DNA of bacteriophage A B2B5
(a gift of Dr. P. Lebowitz) (11), which was analyzed in a
parallel gradient (data now shown). Analysis of the cRNA
by acrylamide gel electrophoresis in formamide demonstrated
that the bulk of the cRNA migrated with the faster moving
components of reticulocyte transfer RNA (4S RNA), added
as a marker (data not shown).
Fingerprint Pattern of the Globin cRNA. Fig. 1 shows the
autoradiograph of a two-dimensional fractionation ("finger-
print") of a RNase T1 digest of human (sickle cell anemia)
globin cRNA labeled with [a-32P]GTP. The pattern is quite
reproducible and specific for cRNA synthesized from human
globin cDNA. The same pattern was obtained with cRNA
derived from different mRNA preparations of the same
patient and from mRNA of six unrelated patients with sickle
cell anemia and that of another patient with Hb A and hemo-
lytic anemia. Neither the use of different batches of DNA
polymerase for the synthesis of cDNA nor the addition of
manganese (0.8 mM) to the RNA polymerase reaction re-
sulted in a qualitatively different fingerprint pattern of the
cRNA. The same pattern was also obtained from the cRNA
when, instead of partially purified (sucrose gradient-frac-
tionated) mRNA, 10S RNA purified by acrylamide gel or
oligo(dT)-cellulose chromatography was used for the syn-
thesis of cDNA. On the other hand, different and distinctive
fingerprint patterns were obtained with RNase TI digests of
mouse, rabbit, and duck globin cRNA (data not shown).
The specificity and fidelity of the cRNA fingerprint is
further illustrated by the fact that the fingerprint pattern
of natural 10S globin mRNA is similar to that of the cRNA.
Pure human globin 10S mRNA, purified by oligo(dT)-cellu-
lose column chromatography, was labeled with 125I (25),
then digested with RNase T1. The fingerprint pattern of this
in vitro labeled natural 10S mRNA (derived from a patient
with Hb A rather than HbS) is shown in Fig. 2. The finger-
print pattern is very similar to that of the cRNA (Fig. 1).
Most of the large oligonucleotides present in the natural 10S
mRNA fingerprint are also present in the cRNA, but the
natural 10S RNA fingerprint does contain a few additional
spots, indicated by the arrows. The mobilities of some of the
spots differ somewhat in the two fingerprints, making exact
matching occasionally equivocal. Differences in mobility
in the first dimension may be caused by the modification of
the cytosine residues by 1251 (37). Nevertheless, the overall
patterns are unequivocally quite similar. A sample of the
same natural 10S RNA, which was labeled in vitro (after
simultaneous digestion with RNase T1 and alkaline phos-
phatase) by means of ['y-32PJATP and polynucleotide kinase,
also gave a fingerprint pattern similar to that of the cRNA,
but with a few additional spots (data not shown).
The absence of certain oligonucleotides in the cRNA
Proc. Nat. Acad. Sci. USA 71 (1974)
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FIG. 1. Autoradiograph of the fingerprint of a Ti RNase
digest of cRNA, synthesized from human (sickle cell anemia)
globin cDNA, in the presence of [a-32P]GTP. The RNA was
partially purified by (Me)2S0-sucrose gradient (22) before di-
gestion. Fractionation, in the first dimension (left to right) was by
electrophoresis on Cellogel®)-urea strip at pH 3.5 (15-17), and
in the second dimension (bottom to top) by homochromatography
(17) on thin-layer plate of DEAE-cellulose.
fingerprint indicates that the cRNA (and presumably the
cDNA) is not a complete copy of the natural mRNA. The
globin cRNA, therefore, is a faithful although incomplete
representation of the natural lOS globin mRNA and contains
most, although not all, of its sequence information, probably
in the form of a heterogeneous group of fragments shorter
than the original mRNA and cDNA.
Nucleotide Sequences of Human Gloin cRNA. The nucleo-
tide sequences of the individual oligonucleotides obtained
after RNase Ti digestion of the cRNA were further studied
by pancreatic RNase (and in some cases U2 RNase) digestion
of the eluted spots. By combining the information, obtained
from separate digests of the four types of labeled RNA, that
were synthesized in the presence of only one radioactive
ribonucleoside triphosphate, a great deal of sequence informa-
tion can be obtained through "nearest-neighbor analysis'2
the labeled phosphate, after digestion with Ti or pancreatic
RNase, is associated with the nucleotide adjacent and to the
5'-side of the labeled precursor nucleotide. For instance, the
labeled phosphate of [a-'2PJGTP, incorporated into the se-
quence ~C*pGp- would be found with-C*p after hydrol-
ysis. In addition, the 5'-terminal nucleotide sequences of the
various spots was confirmed by analysis of the corresponding
oligonucleotides of a RNase Ti digest of natural lOS RNA,
labeled by means of ['y-32P]ATP and polynucleotide kinase.
Additional sequence information was also obtained from
analysis of the oligonucleotides of 1251-labeled natural lOS
mRNA. Sufficient sequence information is available, in the
case of approximately half of the intermediate-sized oligo-
nucleotides (8-14 base residues), to establish a single or
limited number of linear sequence possibilities. This informa-
tion was then analyzed by a computer, which considered all
possible sequence permutations consistent with the sequence
information of each spot and matched them to the possible
codons for the amino-acid sequence of each globin chain;
[a similar technique has been used by others (27, 28)1]. Table
1 lists nine nucleotide sequences of the cRNA that can be
matched to unique amino-acid sequences in the a- or ,8-gl~obin
chains. None of these nucleotide sequences (or their permuta-
tions) can be matched to other amino-acid sequences in
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FIG. 2. Autoradiograph of the fingerprint of a T1 RNase
digest of natural human lOS globin mRNA. lOS mRNA
was purified from the reticulocyte RNA of a patient with Hb A
and hemolytic anemia by sucrose gradient centrifugation,
followed by oligo(dT)-cellulose column chromatography. The
RNA was labeled with 115I (25), then digested with T1 RNase,
and fractionated as in Fig. 1. The spots are numbered as in Fig. 1;
the arrows indicate spots present in the fingerprint of natural
lOS RNA, which are absent in the fingerprint of the cRNA
(Fig. 1).
either a- or fl-globin chains. The probability of error in se-
quences of this length is relatively low in view of the unique-
ness of the match between nucleotide and amino-acid sequence
(27,28).
The validity of the sequence assignments of Table 1 is
reinforced by the fact that the oligonucleotides that match
#3-chain sequences are very prominent, whereas those that
match a-chain sequences are very faint and barely visible
in the fingerprint of cRNA of a patient with a thalassemia
(Hb H disease) and marked deficiency of a-chain mRNA, pre-
viously demonstrated by RNA-DNA hybridization (26).
All but two of the amino-acid sequences represented in
Table 1 are situated in the distal (COOH-terminal) two-
thirds of the , chain. The two a-chain sequences are situated
in the distal 15% of the a chain. These results suggest that the
cDNA is primarily a representation of the central and 3'-
terminal portions of the mRNA. The 5'-terminal portion of
the mRNA may not be represented in the cDNA. The oligo-
nucleotides present in the natural 10S mRNA (Fig. 2) but
absent in the cRNA (Fig. 1) are therefore likely to correspond
to the 5'-terminal portion of the mRNA.
Table 2A lists the sequences of two other oligonucleotides
of intermediate length, which cannot be matched to any a-
or prglobin amino-acid sequences, in spite of all the permuta-
tions allowed by the ambiguousness of their sequences. These
sequences presumably represent untranslated portions of the
mRNA. In addition, these sequences do not match amino-
acid sequences in the abnormally long segment of the Hb
Constant Spring chain, which presumably results from a
chain-termination mutation, allowing translation of a nor-
mally untranslated portion of the a-chain mRNA (29, 30).
Three other sequences, however, have been identified that
do match amino-acid sequences of the a Constant Spring-
globin chain. They are listed in Table 2B. Spot no. 14 is the
longest and it is a unique match. Spot no. 51 is a mixture of
at least two sequences, (G)CCCUG(G) and (G) [C2,U]CG(G),
Proc. Nat. Acad. Sci. USA 71 (1974)
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TABLE 1. Nucleotide sequences of human globin cRNA that match unique globin-chain amino-acid sequences
Spot Spot
no. Sequence Chain no. Sequence Chain
3t ACC[U] [C]CAAAUACCG 21* AACUUCAG
136 137 138 139 140 141 101 102 103 104
Leu Thr Ser Lys Tyr Arg Alpha Glu Asn Phe Arg Beta
NN(G)-ACC-UCC-AAA-UAC-CG(U) NN(G)-AAC-UUC-AG(G)
7* ACAACCUCAAG 22t CCUCA[C] [U]UG
79 80 81 82 83 123 124 125 126
Asp Asn Leu Lys Gly Beta Ala Ser Leu Asp Alpha
(G)AC-AAC-CUC-AAG-(G)NN (G)CC-UCA-CUU-G(A)N
11* CCCAUCACUUUG 28* CACCUUUG
115 116 117 118 119 83 84 85 86
Ala His His Phe Gly Beta Gly Thr Phe Ala Beta
(G)CC-CAU-CAC-UUU-G(G)N N(G)C-ACC-UUU--GNN
12* U[AUC] [ACU]AAG 30* CCACACUG
144 145 146 86 87 88 89
Lys Tyr His Term Beta Ala Thr Leu Ser Beta
NN(G)-UAU-CAC-UAA-G(C)N (G)CC-ACA-CUG-(A)NN
13* GC [AACCJ [CU]AAG
56 57 58 59 60
Gly Asn Pro Lys Val Beta
(G)GC-AAC-CCU-AAG-(G)NN
The spot numbers refer to Fig. 1. The sequences listed are based on the composite information obtained by pancreatic RNase (and in some
cases, U2 RNase) digestion of the oligonucleotide from T1 RNase digests of the cRNA, labeled, in separate experiments, with a different
one of the four [a-32P]nucleoside triphosphates. The sequence of the 5'-terminus of the oligonucleotides was confirmed by analysis of
the corresponding oligonucleotides of the natural lOS mRNA labeled by polynucleotide kinase. Many internal sequences were confirmed
by study of the corresponding oligonucleotides of the 12II-labeled natural lOS mRNA, analyzed by partial and complete pancreatic
RNase digestion and U2 RNase digestion. Listed first is the sequence determined solely by analysis of nucleotide sequence data. The
positions of the nucleotides in brackets can be interchanged on the basis of sequence data alone. Listed under the sequence is the
unique amino-acid sequence matched to the nucleotide sequence by computer analysis, and the corresponding codon grouping of the
nucleotide sequence. The nucleotides in parentheses at the 3a-terminus (right) and 5'-terminus (left) of the hyphenated nucleotide sequence
are not contained in the numbered oligonucleotide but are known to be present in the indicated position by "nearest-neighbor" analysis
(see text) and by the nature of the nuclease (T1 RNase) digest, respectively. N indicates an unknown nucleotide in a codon. The numbers
over the sequences refer to the position of the indicated amino acid in either the a- or f-globii chain.
*The oligonucleotide is prominent in the fingerprint of alpha thalassemia cRNA.
t The oligonucleotide is faint or absent in the fingerprint of alpha thalassemia cRNA.
one of which, (G)CCUCG(G), matches the Hb Constant
Spring a-chain sequence positions 145 to 147.
Spot no. 56 also contains a mixture of sequences: (G)UU-
AAG(C), (G)UAAUG, and (G)AUUAG(C), among them the
sequence (G)UUAAG(C) which matches the a-chain COOH-
terminal amino acid (no. 141), the chain-termination codon
(position 142), and the start of the codon for amino-acid no.
143 of the a Constant Spring chain. The sequence of spot no.
56 is entirely consistent with the current hypothesis of the
origin of Hb Constant Spring by chain-termination codon
mutation: UAA to CAA (term. to Gln) (30).
The sequences of spots no. 51 and no. 56 listed in Table
2B were sequences predicted for a chain mRNA by Seid-
Akhavan et al. by correlating the a-chain amino-acid sequence
of Hb Constant Spring to that of Hb Wayne, a presumed
frameshift mutation in the a-chain mRNA at amino-acid
position no. 139 (31). If both of these mutant hemoglobins
resulted from the type of mutation proposed, then a unique
mRNA sequence of 26 base residues can be predicted, from
the genetic code, for this region of the a-chain mRNA (31,
32). The sequence of spot no. 3 (Table 1) extends this derived
sequence of the a-chain mRNA 10 more residues to the 5'-
side.
Presence of Poly(A) Sequences in the cRNA. When cRNA
is synthesized in the present of [a-'2P]ATP, the fingerprint
of the RNase T1 digest of the RNA reveals a very prominent
spot that has properties similar to that of the long poly(A)
sequence identified by Brownlee et al. in immunoglobulin L-
TABLE 2. Nucleotide sequences of human globin cINA
Spot no. Sequence
(A) Sequences that do not match known globin
chain amino-acid sequences
6* [G]U[AAU,AU,U3_5,C2,]3AAAG(G)
25* [G]U[AU,_2,U.2]1AUG(A)
(B) Sequences that match or overlap amino-acid
sequences in the a Constant Spring-globin chain
14t (G)[CU,C,C,C]CAACG(G)
155 156 157 158
Ala Ser Gln Arg
(G)CC-UCC-CAA-CG(G)
51t 145 146 147
Ala Ser Val
(G)CC-UCG-(G)NN
56t 141 142 143
Arg Term Ala
N(G)U-UAA-G(C)N
The sequence information was obtained and is expressed as in
legend of Table 1. The exact sequence of the nucleotides in
brackets cannot yet be determined from the sequence information
alone. The sequence listed for spot no. 51 also matches the amino-
acid sequence of a-chain position 130-131. The sequence listed for
spot no. 56 also matches [in a different codon grouping: NN(G)-
UIJA-AG(C) = y-Leu-Ser] the following amino-acid sequences:
87-89; a 1-3; a 79-81; a 82-84 and a 100-102.
* and t See Table 1.
Proc. Nat. Acad. Sci. USA 71 (1974)
2304 Cell Biology. Marotta et al.
chain mRNA (28). However, the size of this poly(A) sequence
in globin cRNA has not yet been precisely determined. What-
ever its size, it may not be a true representation of the poly(A)
sequence of the natural mRNA, because a long poly(A) se-
quence could possibly be transcribed by "slipping" of the
RNA polymerase on the oligo(dT)1218 primer that is used in
the synthesis of the cDNA and is presumably linked to the
5'-terminus of the cDNA.
DISCUSSION
The 32P-labeled cRNA transcribed by E. coli RNA poly-
merase from human globin cDNA can be used to study the
nucleotide sequence of a mRNA that cannot be otherwise
efficiently labeled with 32p in vivo or in tissue culture. The
method is specific and reproducible and has the added advan-
tage that a great deal of sequence information can be obtained
by the use of only one labeled nucleoside triphosphate pre-
cursor at a time, which results in the labeling of the nearest-
neighbor nucleotide in the RNA. The process of transcription
of mRNA into cDNA and of cDNA into cRNA appears to be
faithful, as evidenced by the fact-that, on the basis of sequence
information from roughly 50% of the oligonucleotides 8-14
base residues long, approximately 70% of the oligonucleo-
tides of the cRNA can be matched to unique amino-acid
sequences of the a- or P-globin chains. This percentage is
roughly what would be expected from the size of the natural
mRNA, which is estimated to have a molecular weight of
200,000 to 220,000 (33-36) (approximately 650 base residues)
and, therefore, is approximately 30% longer than necessary
to simply code for globin chains of 141 to 146 amino acids.
Although the cRNA is smaller than the natural mRNA (4 S
compared to 10 S), it appears to contain the majority of the
sequences of the natural mRNA: the fingerprint patterns of
digests of natural 10S RNA, labeled by 125I and by [,y-32P]
ATP with polynucleotide kinase, are very similar to that of
the- cRNA and contain only a few additional oligonucleo-
tides, not present in the fingerprint of the cRNA.
Salser et al. (38) have reported nucleotide sequence studies
of rabbit globin cRNA; three sequences, 6-9 base residues
long, were identified, which match amino-acid sequences in
the rabbit a- or ,B-globin chain. Proudfoot and Brownlee have
identified a unique nucleotide sequence (AUUGC) adjacent
to the poly(A) sequence of rabbit globin mRNA, by sequence
analysis of short cDNA transcripts obtained by incubating
rabbit globinmRNA with E. coliDNA polymerase I (40).
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